X
SRNE

Xponance’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Xponance’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,348
Closed -$23.3K – 1266
2022
Q4 		$23.3K Buy
26,348
+5,115
+24% +$6.79K ﹤0.01% 1211
2022
Q3 		$33K Buy
21,233
+945
+5% +$2.14K ﹤0.01% 1168
2022
Q2 		$41K Buy
20,288
+6,088
+43% +$10.5K ﹤0.01% 1166
2022
Q1 		$33K Buy
14,200
+117
+0.8% +$365 ﹤0.01% 1152
2021
Q4 		$65K Buy
14,083
+1,015
+8% +$6.3K ﹤0.01% 1149
2021
Q3 		$100K Sell
13,068
-1,857
-12% -$15.7K ﹤0.01% 1139
2021
Q2 		$145K Buy
+14,925
New +$119K ﹤0.01% 1199

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Xponance's SRNE Position: Q1 2023 in Review

Xponance sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 26,348 shares — an estimated $23.3K sold.

Xponance first reported a position in SRNE in Q2 2021 and held it in 7 quarters. The position peaked at $145K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Xponance reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Xponance sold 26,348 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $23.3K.
  • Xponance first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 7 quarters.
  • Xponance's Sorrento Therapeutics, Inc. position peaked at $145K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Xponance's 13F filing for Q1 2023, filed 18 Apr 2023.